COSMOS Pharmaceutical Corporation

3349

JP3298400007

Drug Retailers

Delayed Japan Exchange Other stock markets 11:30:00 30/04/2024 am IST			5-day change	1st Jan Change
14,550 ^JPY	+1.11%		+0.59%	-10.65%

12/04	Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months	MT
12/04	COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	CI

Hidefuji Co., Ltd. acquired 5.25% stake in COSMOS Pharmaceutical Corporation from Masateru Uno.

January 31, 2018

Hidefuji Co., Ltd. acquired 5.25% stake in COSMOS Pharmaceutical Corporation (TSE:3349) from Masateru Uno on January 31, 2018. Hidefuji Co., Ltd. acquired 1.04 million shares of COSMOS Pharmaceutical Corporation. Hidefuji Co., Ltd. completed the acquisition of 5.25% stake in COSMOS Pharmaceutical Corporation (TSE:3349) from Masateru Uno on January 31, 2018.

Latest news about COSMOS Pharmaceutical Corporation

Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months	12/04	MT
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	12/04	CI
Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores	12/01	MT
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	12/01	CI
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending May 31, 2024, Payable on February 13, 2024; Provides Year Dividend Guidance for fiscal Year Ending May 31, 2024	12/01	CI
Cosmos Pharmaceutical’s Attributable Profit up marginally by 0.4% in Fiscal Q1 After Opening New Stores	12/23/12	MT
COSMOS Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended August 31, 2023	11/23/11	CI
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	11/23/11	CI
Cosmos Attributable Profit Increases 2.8% in Fiscal Year 2023	11/23/11	MT
COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Year Ended May 31, 2023, Payable on August 3, 2023; Provides Dividend Guidance for the Second Quarter-End and Full Year of Full Year Ending May 31, 2024	10/23/10	CI
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	10/23/10	CI
Cosmos Pharma's Attributable Profit Slides 1% in Fiscal Nine Months Amid New Store Openings	11/23/11	MT
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023	10/23/10	CI
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal year ending May 31, 2023	10/23/10	CI
Cosmos Pharma Books Marginal Rise in Fiscal H1 Attributable Profit Amid New Store Openings, Low-cost Strategy	16/23/16	MT
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter of Fiscal 2023; Provides Dividend Guidance for the Full Year of Fiscal Year Ending May 31, 2023	13/23/13	CI
Cosmos Pharmaceutical Corporation Provides Earnings Forecast for the Fiscal Year Ending May 31, 2023	13/23/13	CI
Cosmos Pharma Clocks Higher Profit, Revenue in Fiscal Q1 on New Store Openings	12/22/12	MT
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Second Quarter-End and Full Year of Fiscal Year Ending May 31, 2023	11/22/11	CI
UBS Adjusts COSMOS Pharmaceutical’s Price Target to 15,500 Yen From 16,500 Yen, Keeps at Neutral	12/22/12	MT
Cosmos Pharmaceutical Logs Lower Profit in FY22 Despite Jump in Net Sales; Shares Climb 6%	12/22/12	MT
COSMOS Pharmaceutical Corporation Announces Dividend Guidance for the Second Quarter and Year End of Fiscal Year Ending May 31, 2023	11/22/11	CI
UBS Adjusts Cosmos Pharmaceutical's Price Target to 16,500 Yen From 17,500 Yen, Keeps at Neutral	28/22/28	MT
Global markets live: Baidu, Cisco, Nvidia, Amazon, Apple...	18/21/18
COSMOS Pharmaceutical : Topix closes at near one-month high as investors await earnings	13/21/13	RE

Chart COSMOS Pharmaceutical Corporation

Duration

Period

More charts

Company Profile

COSMOS Pharmaceutical Corporation is a company primarily engaged in the operation of drug stores. The Company offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous goods include baby goods, detergents, insecticides, deodorizers, bath goods, toiletries, cookware, gardening goods, automobile goods and clothing products. General food products include processed food products, daily food products, seasonings, confectionery, non-alcoholic beverages and alcoholic beverages. It also provides tobacco and others.

Sector

Drug Retailers

Calendar

30/05/2024 - Final dividend

More about the company

Income Statement Evolution

More financial data

Ratings for COSMOS Pharmaceutical Corporation

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

14,390 JPY

Average target price

16,620 JPY

Spread / Average Target

+15.50%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Retail - Drugs with Grocery

	1st Jan change	Capi.
COSMOS PHARMACEUTICAL CORPORATION	-10.65%	3.64B
SUNDRUG CO.,LTD.	+1.28%	3.38B
SUGI HOLDINGS CO.,LTD.	+7.42%	2.68B
LBX PHARMACY CHAIN	+9.74%	2.65B
KUSURI NO AOKI HOLDINGS CO., LTD.	-7.95%	1.76B
CREATE SD HOLDINGS CO., LTD.	+11.42%	1.35B
GREAT TREE PHARMACY CO., LTD.	-18.45%	984M
SHUYU CIVILIAN PHARMACY CORP., LTD.	-38.18%	707M
FARMACIAS BENAVIDES, S.A.B. DE C.V.	-0.53%	454M
CAWACHI LIMITED	+7.31%	371M

Retail - Drugs with Grocery

COSMOS Pharmaceutical Corporation

Equities

3349

JP3298400007

Drug Retailers

Hidefuji Co., Ltd. acquired 5.25% stake in COSMOS Pharmaceutical Corporation from Masateru Uno.

EPS Revisions